Combining Magrolimab and Azacitidine for Higher-Risk MDS Treatment
Physician's Weekly,
The following is a summary of “Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes…
Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study
Overview of attention for article published in Journal of Clinical Oncology, March 2023
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (97th percentile)
-
High Attention Score compared to outputs of the same age and source (90th percentile)
Readers on
- mendeley
- 109 Mendeley